<DOC>
	<DOCNO>NCT02831283</DOCNO>
	<brief_summary>This study do learn inflammation amyloid Alzheimer 's disease . A type brain scan call PET scan use measure 1 ) inflammation 2 ) abnormal accumulation amount certain protein fragment call beta-amyloid ( plaque ) brain . These think involve Alzheimer 's disease . The investigator also perform brain MRI test measure participant ' memory thinking .</brief_summary>
	<brief_title>Imaging Inflammation Alzheimer 's Disease</brief_title>
	<detailed_description>This study do determine relationship inflammation , cognitive impairment , amyloid burden elderly subject different clinical biomarker profile Alzheimer 's disease ( AD ) . Participants undergo amyloid PET image 18F-Florbetaben target number completers 15 amyloid-positive elder impairment , 15 amyloid-positive elder normal cognition , 15 amyloid-negative elder impairment , 15 amyloid-negative elder normal cognition . Subjects undergo screen include neuropsychological testing , brain MRI , PET image 18F-florbetaben define 4 group . Subjects 11C-PBR28 PET imaging measure 18 kDa translocator protein ( marker inflammation ) . Subjects option lumbar puncture perform measure CSF concentration amyloid , tau , phospho-tau , inflammatory marker .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1 . Age 60 old . 2 . Meet criterion either ) amnestic mild cognitive impairment ( single mixed domain ) mild Alzheimer 's disease , b ) cognitive impairment base history , exam , neuropsychological testing , consensus diagnosis . MCI mild AD patient must Clinical Dementia Rating scale score 0.5 1 . Unimpaired subject must Clinical Dementia Rating scale score 0 . 3 . Subjects unable provide inform consent must surrogate decision maker 4 . Written oral fluency English Spanish . 5 . Able participate schedule evaluation complete require test procedure . 6 . In opinion investigator , subject must consider likely comply study protocol high probability complete study . 1 . Past present history certain brain disorder MCI AD . 2 . Certain significant medical condition , make study procedure current study unsafe . 3 . Contraindication MRI scanning . 4 . Conditions preclude entry scanner ( e.g. , morbid obesity , claustrophobia , etc. ) . 5 . Exposure research relate radiation past year , combine study , would place subject allowable limit . 6 . Low affinity bind TSPO genetic screen . 7 . Participation last year clinical trial disease modify drug AD . 8 . Inability catheter subject 's vein injection radioligand . 9 . Inability blood drawn subject 's vein .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>inflammation</keyword>
	<keyword>age</keyword>
	<keyword>mild cognitive impairment</keyword>
</DOC>